This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Metimedi Pharmaceuticals Co., Ltd, Metimedi Pharmaceuticals Co., Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Keun-Yeong Jeong: Innovator in Chronic Inflammatory Disease Treatment
Introduction
Keun-Yeong Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of chronic inflammatory diseases. With a total of 7 patents to his name, Jeong's work has the potential to impact many lives.
Latest Patents
Among his latest patents, Jeong has developed methods for treating chronic inflammatory diseases. This invention involves administering calcium lactate as an active agent to subjects in need. The calcium lactate can be incorporated into pharmaceutical, food, or nutrient compositions. Another notable patent focuses on pharmaceutical compositions that include calcium lactate along with polysaccharides, polymers, lipids, or combinations thereof. These compositions are particularly useful in treating cancer and can also be found in food and nutrient formulations.
Career Highlights
Throughout his career, Jeong has worked with various companies, including Metimedi Pharmaceuticals Co., Ltd and Pearlsinmires Co., Ltd. His innovative approaches and dedication to research have established him as a key figure in his field.
Collaborations
Jeong has collaborated with notable individuals such as Chong-Hwan Chang and Chong Hwan Chang. These partnerships have further enhanced his research and development efforts.
Conclusion
Keun-Yeong Jeong's contributions to the treatment of chronic inflammatory diseases and cancer through innovative use of calcium lactate highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile